Array partnered with Roche's Genentech Inc. unit to develop each company's oral checkpoint kinase 1 (Chk1) inhibitor for cancer

Array BioPharma Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

$127.1m on 08/12/2011 [market cap]

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Roche

Switzerland / Large-Cap Biopharma (>=$50 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced